Immunohistochemical analysis of markers for different macrophage phenotypes and their use for a forensic wound age estimation.
A total of 117 vital skin wounds (post infliction intervals between a few seconds and 7 months), 20 postmortem wounds and skin specimens with beginning or advanced signs of putrefaction were investigated. Different markers for macrophage maturation (27 E 10, RM 3/1, 25 F 9, G 16/1) were analyzed by immunohistochemistry. The early stage inflammation marker 27 E 10 stained macrophages, but also monocytes and neutrophilic granulocytes localized in blood vessels or bleeding induced postmortem and therefore provided no further information for a forensic wound age estimation in comparison to the routine histological detection of macrophages. The antigens recognized by the RM 3/1- (intermediate stage inflammation marker) and 25 F 9-antibodies (late stage inflammation marker) were expressed exclusively by histiocytes and inflammatory cells that had migrated from the blood vessels as part of the acute inflammatory response associated with an intravital reaction. The morphometrical analysis revealed positive results (defined as at least a two-fold increase in number in 2 or more microscope fields when compared to the maximum value of histiocytes found in uninjured skin) for the RM 3/1- or 25 F 9-antibody earliest in wounds aged 7 or 11 days, respectively. Similarly to the 25 F 9-antibody, the chronic stage inflammation marker (G 16/1) reacted with a macrophage subpopulation first detectable 12 days after wounding but showed positive results in a comparably reduced percentage of cases. On the other hand, this marker did not stain a relevant number of resident macrophages thus facilitating the evaluation of the specimens.(ABSTRACT TRUNCATED AT 250 WORDS)
Betz
P
P
Department of Legal Medicine, University of Munich, Germany.
Tübel
J
J
Eisenmenger
W
W
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000943:Antigens, Differentiation / Q000032:analysis*; D000954:Antigens, Surface / Q000032:analysis; D015415:Biomarkers; D005260:Female; D006097:Granulation Tissue / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000473:pathology; D008262:Macrophage Activation / Q000502:physiology*; D016215:Macrophage-Activating Factors / Q000032:analysis*; D008264:Macrophages / Q000145:classification / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011180:Postmortem Changes; D012867:Skin / Q000293:injuries* / Q000473:pathology; D014945:Wound Healing / Q000502:physiology*; D014951:Wounds, Stab / Q000473:pathology
D000943:Antigens, Differentiation; D000954:Antigens, Surface; D015415:Biomarkers; D016215:Macrophage-Activating Factors